StockNews.com began coverage on shares of ClearOne (NASDAQ:CLRO – Free Report) in a research report released on Tuesday. The firm issued a hold rating on the communications equipment provider’s stock.
ClearOne Price Performance
CLRO stock opened at $0.67 on Tuesday. The company has a market capitalization of $16.00 million, a P/E ratio of -9.54 and a beta of 0.82. The business has a 50-day moving average price of $0.81 and a 200 day moving average price of $1.04. ClearOne has a 1-year low of $0.63 and a 1-year high of $2.48.
ClearOne (NASDAQ:CLRO – Get Free Report) last announced its earnings results on Monday, May 20th. The communications equipment provider reported ($0.08) EPS for the quarter. The firm had revenue of $3.62 million during the quarter. ClearOne had a negative return on equity of 12.92% and a negative net margin of 8.96%.
Institutional Investors Weigh In On ClearOne
ClearOne Company Profile
ClearOne, Inc, together with its subsidiaries, designs, develops, and sells conferencing, collaboration, and network streaming solutions for voice and visual communications in the United States and internationally. The company offers a range of audio conferencing products, including professional audio conferencing and sound-reinforcement products for use in enterprise, healthcare, education and distance learning, government, legal, and finance organizations; mid-tier premium conferencing products for smaller rooms, and small and medium businesses, which interface with video and Web conferencing systems; USB-based personal and group speakerphones that could be used with PCs, laptops, tablets, smartphones, and other portable devices; and traditional tabletop conferencing phones used in conference rooms and offices.
Featured Articles
- Five stocks we like better than ClearOne
- Dividend Capture Strategy: What You Need to Know
- RXO Shares Surge Following New Acquisition Deal
- Investing in the High PE Growth Stocks
- 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
- What is a SEC Filing?
- Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Receive News & Ratings for ClearOne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ClearOne and related companies with MarketBeat.com's FREE daily email newsletter.